TP53 and cancer: We found that inactivation of p53 in MCF-7 and HCT-116 cells resulted in increased expression of TAp73, but not DNp73, which suggests that p53 inactivation-mediated-upregulation of p73 may contribute to the p73 overexpression detected in human cancers.